Abstract
Herbal usage remains popular as an alternative or complementary form of treatment, especially in Africa. However, the misconception that herbal remedies are safe due to their “natural” origins jeopardizes human safety, as many different interactions can occur with concomitant use with other pharmaceuticals on top of potential inherent toxicity. Cytochrome P450 enzymes are highly polymorphic, and pose a problem for pharmaceutical drug tailoring to meet an individual’s specific metabolic activity. The influence of herbal remedies further complicates this. The plants included in this review have been mainly researched for determining their effect on cytochrome P450 enzymes and P-glycoprotein drug transporters. Usage of herbal remedies, such as Hypoxis hemerocallidea, Sutherlandia frutescens and Harpagophytum procumbensis popular in Africa. The literature suggests that there is a potential for drug-herb interactions, which could occur through alterations in metabolism and transportation of drugs. Research has primarily been conducted in vitro, whereas in vivo data are lacking. Research concerning the effect of African herbals on drug metabolism should also be approached, as specific plants are especially popular in conjunction with certain treatments. Although these interactions can be beneficial, the harm they pose is just as great.
©2011 by Walter de Gruyter Berlin Boston
Artikel in diesem Heft
- Editorial
- Ageing populations, complex diseases and their challenge to 21st century healthcare: the focus of the European Society for Pharmacogenomics and Theranostics
- Reviews
- Clopidogrel pharmacogenetics: metabolism and drug interactions
- Drug interactions in African herbal remedies
- Minireview
- Experimental evidence of the potential use of erythropoietin by intranasal administration as a neuroprotective agent in cerebral hypoxia
- Original Articles
- A comparison of simple allometric and maturation models for the prediction of morphine clearance in pediatrics
- Rhabdomyolysis-induced acute renal failure due to itraconazole and simvastatin association
- Stereoselective binding of chiral anti-diabetic drug nateglinide to plasma proteins
- Abstracts
- 4th BBBB – Bled International Conference on Pharmaceutical Sciences
Artikel in diesem Heft
- Editorial
- Ageing populations, complex diseases and their challenge to 21st century healthcare: the focus of the European Society for Pharmacogenomics and Theranostics
- Reviews
- Clopidogrel pharmacogenetics: metabolism and drug interactions
- Drug interactions in African herbal remedies
- Minireview
- Experimental evidence of the potential use of erythropoietin by intranasal administration as a neuroprotective agent in cerebral hypoxia
- Original Articles
- A comparison of simple allometric and maturation models for the prediction of morphine clearance in pediatrics
- Rhabdomyolysis-induced acute renal failure due to itraconazole and simvastatin association
- Stereoselective binding of chiral anti-diabetic drug nateglinide to plasma proteins
- Abstracts
- 4th BBBB – Bled International Conference on Pharmaceutical Sciences